Published in Biotech Business Week, May 28th, 2007
"There were 101 non-responders and 53 relapsers to standard combination therapy. Patients were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.